Topiramate as a Disease Modifying Therapy for Cryptogenic Sensory Peripheral Neuropathy (CSPN)
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2018
At a glance
- Drugs Topiramate (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms TopCSPN
- 24 Mar 2018 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 24 Mar 2018 Planned primary completion date changed from 1 Dec 2020 to 1 Mar 2019.
- 24 Mar 2018 Status changed from not yet recruiting to recruiting.